A detailed history of Odey Asset Management Group LTD transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Odey Asset Management Group LTD holds 2,499,400 shares of AUTL stock, worth $4.47 Million. This represents 1.52% of its overall portfolio holdings.

Number of Shares
2,499,400
Previous 2,499,400 -0.0%
Holding current value
$4.47 Million
Previous $4.75 Million 3.16%
% of portfolio
1.52%
Previous 1.45%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$1.74 - $3.27 $4.35 Million - $8.17 Million
2,499,400 New
2,499,400 $4.75 Million

Others Institutions Holding AUTL

About Autolus Therapeutics plc


  • Ticker AUTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 90,909,800
  • Market Cap $163M
  • Description
  • Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...
More about AUTL
Track This Portfolio

Track Odey Asset Management Group LTD Portfolio

Follow Odey Asset Management Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Odey Asset Management Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Odey Asset Management Group LTD with notifications on news.